MDT Stock Overview
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 6/6 |
Rewards
Risk Analysis
No risks detected for MDT from our risk checks.
Medtronic plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$22,433.00 |
| 52 Week High | US$28,700.00 |
| 52 Week Low | US$10,019.50 |
| Beta | 0.80 |
| 1 Month Change | 6.82% |
| 3 Month Change | -14.70% |
| 1 Year Change | 112.43% |
| 3 Year Change | 351.19% |
| 5 Year Change | n/a |
| Change since IPO | 182,653.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDT | AR Medical Equipment | AR Market | |
|---|---|---|---|
| 7D | -1.1% | 0% | 0% |
| 1Y | 112.4% | 0% | 0% |
Return vs Industry: MDT exceeded the AR Medical Equipment industry which returned -0.6% over the past year.
Return vs Market: MDT underperformed the AR Market which returned 321.7% over the past year.
Price Volatility
| MDT volatility | |
|---|---|
| MDT Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in AR Market | 0% |
| 10% least volatile stocks in AR Market | 0% |
Stable Share Price: MDT has not had significant price volatility in the past 3 months.
Volatility Over Time: MDT's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 95,000 | Geoff Martha | www.medtronic.com |
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
Medtronic plc Fundamentals Summary
| MDT fundamental statistics | |
|---|---|
| Market cap | AR$97.12t |
| Earnings (TTM) | AR$3.71t |
| Revenue (TTM) | AR$28.54t |
26.2x
P/E Ratio3.4x
P/S RatioIs MDT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDT income statement (TTM) | |
|---|---|
| Revenue | US$32.32b |
| Cost of Revenue | US$11.08b |
| Gross Profit | US$21.24b |
| Other Expenses | US$17.04b |
| Earnings | US$4.20b |
Last Reported Earnings
Jan 26, 2024
Next Earnings Date
May 23, 2024
| Earnings per share (EPS) | 3.16 |
| Gross Margin | 65.72% |
| Net Profit Margin | 13.00% |
| Debt/Equity Ratio | 48.3% |
How did MDT perform over the long term?
See historical performance and comparison